Combining miR-10b–Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast CancerByunghee Yoo, Zdravka Medarova, Alana Ross et al.|Cancer Research|2015Cited by 76
Template-Directed RIG-I Agonist Assembly for Targeted Cancer ImmunotherapySubrata Ghosh, Zdravka Medarova|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0